Cargando…
Resolution of a chronic viral infection after interleukin-10 receptor blockade
A defining characteristic of persistent viral infections is the loss and functional inactivation of antiviral effector T cells, which prevents viral clearance. Interleukin-10 (IL-10) suppresses cellular immune responses by modulating the function of T cells and antigen-presenting cells. In this pape...
Autores principales: | , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2118120/ https://www.ncbi.nlm.nih.gov/pubmed/17030951 http://dx.doi.org/10.1084/jem.20061462 |
_version_ | 1782140952954011648 |
---|---|
author | Ejrnaes, Mette Filippi, Christophe M. Martinic, Marianne M. Ling, Eleanor M. Togher, Lisa M. Crotty, Shane von Herrath, Matthias G. |
author_facet | Ejrnaes, Mette Filippi, Christophe M. Martinic, Marianne M. Ling, Eleanor M. Togher, Lisa M. Crotty, Shane von Herrath, Matthias G. |
author_sort | Ejrnaes, Mette |
collection | PubMed |
description | A defining characteristic of persistent viral infections is the loss and functional inactivation of antiviral effector T cells, which prevents viral clearance. Interleukin-10 (IL-10) suppresses cellular immune responses by modulating the function of T cells and antigen-presenting cells. In this paper, we report that IL-10 production is drastically increased in mice persistently infected with lymphocytic choriomeningitis virus. In vivo blockade of the IL-10 receptor (IL-10R) with a neutralizing antibody resulted in rapid resolution of the persistent infection. IL-10 secretion was diminished and interferon γ production by antiviral CD8(+) T cells was enhanced. In persistently infected mice, CD8α(+) dendritic cell (DC) numbers declined early after infection, whereas CD8α(−) DC numbers were not affected. CD8α(−) DCs supported IL-10 production and subsequent dampening of antiviral T cell responses. Therapeutic IL-10R blockade broke the cycle of IL-10–mediated immune suppression, preventing IL-10 priming by CD8α(−) DCs and enhancing antiviral responses and thereby resolving infection without causing immunopathology. |
format | Text |
id | pubmed-2118120 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2006 |
publisher | The Rockefeller University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-21181202007-12-13 Resolution of a chronic viral infection after interleukin-10 receptor blockade Ejrnaes, Mette Filippi, Christophe M. Martinic, Marianne M. Ling, Eleanor M. Togher, Lisa M. Crotty, Shane von Herrath, Matthias G. J Exp Med Articles A defining characteristic of persistent viral infections is the loss and functional inactivation of antiviral effector T cells, which prevents viral clearance. Interleukin-10 (IL-10) suppresses cellular immune responses by modulating the function of T cells and antigen-presenting cells. In this paper, we report that IL-10 production is drastically increased in mice persistently infected with lymphocytic choriomeningitis virus. In vivo blockade of the IL-10 receptor (IL-10R) with a neutralizing antibody resulted in rapid resolution of the persistent infection. IL-10 secretion was diminished and interferon γ production by antiviral CD8(+) T cells was enhanced. In persistently infected mice, CD8α(+) dendritic cell (DC) numbers declined early after infection, whereas CD8α(−) DC numbers were not affected. CD8α(−) DCs supported IL-10 production and subsequent dampening of antiviral T cell responses. Therapeutic IL-10R blockade broke the cycle of IL-10–mediated immune suppression, preventing IL-10 priming by CD8α(−) DCs and enhancing antiviral responses and thereby resolving infection without causing immunopathology. The Rockefeller University Press 2006-10-30 /pmc/articles/PMC2118120/ /pubmed/17030951 http://dx.doi.org/10.1084/jem.20061462 Text en Copyright © 2006, The Rockefeller University Press This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/). |
spellingShingle | Articles Ejrnaes, Mette Filippi, Christophe M. Martinic, Marianne M. Ling, Eleanor M. Togher, Lisa M. Crotty, Shane von Herrath, Matthias G. Resolution of a chronic viral infection after interleukin-10 receptor blockade |
title | Resolution of a chronic viral infection after interleukin-10 receptor blockade |
title_full | Resolution of a chronic viral infection after interleukin-10 receptor blockade |
title_fullStr | Resolution of a chronic viral infection after interleukin-10 receptor blockade |
title_full_unstemmed | Resolution of a chronic viral infection after interleukin-10 receptor blockade |
title_short | Resolution of a chronic viral infection after interleukin-10 receptor blockade |
title_sort | resolution of a chronic viral infection after interleukin-10 receptor blockade |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2118120/ https://www.ncbi.nlm.nih.gov/pubmed/17030951 http://dx.doi.org/10.1084/jem.20061462 |
work_keys_str_mv | AT ejrnaesmette resolutionofachronicviralinfectionafterinterleukin10receptorblockade AT filippichristophem resolutionofachronicviralinfectionafterinterleukin10receptorblockade AT martinicmariannem resolutionofachronicviralinfectionafterinterleukin10receptorblockade AT lingeleanorm resolutionofachronicviralinfectionafterinterleukin10receptorblockade AT togherlisam resolutionofachronicviralinfectionafterinterleukin10receptorblockade AT crottyshane resolutionofachronicviralinfectionafterinterleukin10receptorblockade AT vonherrathmatthiasg resolutionofachronicviralinfectionafterinterleukin10receptorblockade |